ANKRD52, or Ankyrin Repeat Domain 52, is a gene that encodes a protein involved in various cellular processes, particularly in signal transduction pathways and protein-protein interactions. The ANKRD52 protein belongs to the ankyrin repeat family, characterized by a series of ankyrin repeats, a common protein folding structure used in protein-protein interactions.The ankyrin repeat motif in ANKRD52 consists of tandem repeats of about 33 amino acids, known for their ability to mediate interactions with a diverse range of proteins. This structural feature makes ANKRD52 a versatile player in cellular signaling and regulation.ANKRD52 is known to interact with PP6, a serine/threonine phosphatase. This interaction is crucial for various cellular functions, including the regulation of mitotic spindle formation, a critical process in cell division. ANKRD52 helps localize PP6 to the mitotic spindle, ensuring proper spindle assembly and function during cell division. This role is vital for maintaining genomic stability and preventing errors in cell division that could lead to cancer.
Beyond its role in cell division, ANKRD52 is implicated in other cellular processes such as signal transduction, where it modulates pathways involved in cell growth, proliferation, and survival. The versatility of its ankyrin repeats allows ANKRD52 to be a part of multiple protein complexes, influencing various signaling pathways.ANKRD52's functions and interactions highlight its importance in maintaining cellular homeostasis. Any dysregulation of ANKRD52 can have significant implications, leading to diseases like cancer due to its role in cell cycle regulation and signal transduction pathways. This makes ANKRD52 a target for interventions in various disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
Fostriecin selectively inhibits PP2A, which could indirectly influence ANKRD52 activity in cell signaling processes. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits PP2A and might have an indirect effect on ANKRD52 by modulating associated signaling pathways. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Endothall is a PP2A inhibitor, potentially affecting ANKRD52 function through PP2A-associated pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, a proteasome inhibitor, can affect protein turnover, potentially influencing ANKRD52 activity indirectly. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits the proteasome, potentially impacting ANKRD52 by affecting protein degradation pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, potentially influencing signaling pathways in which ANKRD52 is involved. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride affects the Wnt/β-catenin pathway, potentially influencing ANKRD52 activity in signal transduction. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an HDAC inhibitor, could indirectly impact ANKRD52 through effects on transcriptional regulation. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB216763 is a GSK-3 inhibitor, which could indirectly affect ANKRD52 activity via the Wnt/β-catenin signaling pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor, potentially affecting signaling pathways relevant to ANKRD52's function in cells. | ||||||